Serum UCHL1 increased proportionally, with the number of affected regions, which showed a trend toward higher UCHL1 levels when more regions were involved, although no statistically significant correlation was detected (Figure 5 ).
← all excerpts
UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis.
1
—
—